Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion type Assertion NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_head.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion description "[We investigated whether HLA-A*24 typing complements screening for HLA-DQ and for antibodies (Abs) against insulin, GAD, IA-2 (IA-2A), and zinc transporter-8 (ZnT8A) for prediction of rapid progression to type 1 diabetes (T1D).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_provenance.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion evidence source_evidence_literature NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_provenance.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion SIO_000772 23160529 NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_provenance.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion wasDerivedFrom befree-20150227 NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_provenance.
- NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_assertion wasGeneratedBy ECO_0000203 NP417252.RAdsrHUhMlFqaz6C5sCx20_4jnFsL40PR6aPN3fMQPwL8130_provenance.